Elsevier

EBioMedicine Template

Write in a clean editor, then format for EBioMedicine in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the EBioMedicine format

EBioMedicine is a peer-reviewed journal published by Elsevier, covering SARS-CoV-2 and COVID-19 Research, Gut microbiota and health, COVID-19 Clinical Research Studies.

PublisherElsevier
Reference styleNumbered (Elsevier)
Numbered — [1], [2] in the text
[1] A. Smith, B. Jones, C. Lee, A representative article title, EBioMedicine 12 (2023) 45–58.

Formats any DOI in EBioMedicine style. No sign-up.

Publishes research inSARS-CoV-2 and COVID-19 Research Gut microbiota and health COVID-19 Clinical Research Studies HIV Research and Treatment Epigenetics and DNA Methylation
ISSN2352-3964
Citation impact (2-yr)9.39
h-index181
i10-index3,979
Total citations253,057
Article processing charge$3,500
Open accessYes
Top institutions publishing hereInserm
Journal websitewww.journals.elsevier.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in EBioMedicine per year

55
2014
376
2015
478
2016
402
2017
539
2018
726
2019
578
2020
614
2021
616
2022
507
2023
585
2024
554
2025

Citation impact of EBioMedicine by publication year

1.6K
2014
16K
2015
28K
2016
22.1K
2017
31.3K
2018
39.9K
2019
31.9K
2020
24.8K
2021
25.1K
2022
16.8K
2023
9.5K
2024
3K
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in EBioMedicine

Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients

Jing Liu, Sumeng Li, Jia Liu et al. · 18 Apr 2020

Background The dynamic changes of lymphocyte subsets and cytokines profiles of patients with novel coronavirus disease (COVID-19) and their correlation with the disease severity remain unclear. Methods Peripheral blood samples were longitudinally collected from 40 confirmed COVID-19 patients and examined for lymphocyte subsets by flow cytometry and cytokine profiles by specific immunoassays. Findings Of the…

1,746 citations Cite SaveGo to paper →
Role of gut microbiota in type 2 diabetes pathophysiology

Manoj Gurung, Zhipeng Li, Hannah You et al. · 1 Jan 2020

A substantial body of literature has provided evidence for the role of gut microbiota in metabolic diseases including type 2 diabetes. However, reports vary regarding the association of particular taxonomic groups with disease. In this systematic review, we focused on the potential role of different bacterial taxa affecting diabetes. We have summarized evidence from 42…

1,733 citations Cite SaveGo to paper →
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease

LaTonya J. Hickson, Larissa Prata, Shane A. Bobart et al. · 1 Sep 2019

BACKGROUND: Senescent cells, which can release factors that cause inflammation and dysfunction, the senescence-associated secretory phenotype (SASP), accumulate with ageing and at etiological sites in multiple chronic diseases. Senolytics, including the combination of Dasatinib and Quercetin (D + Q), selectively eliminate senescent cells by transiently disabling pro-survival networks that defend them against their own apoptotic…

1,312 citations Cite SaveGo to paper →
The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey

Heidi J. Larson, Alexandre de Figueiredo, Xiahong Zhao et al. · 14 Sep 2016

BACKGROUND: Public trust in immunization is an increasingly important global health issue. Losses in confidence in vaccines and immunization programmes can lead to vaccine reluctance and refusal, risking disease outbreaks and challenging immunization goals in high- and low-income settings. National and international immunization stakeholders have called for better monitoring of vaccine confidence to identify emerging…

1,284 citations Cite SaveGo to paper →
Biological Age Predictors

Juulia Jylhävä, Nancy L. Pedersen, Sara Hägg · 1 Apr 2017

The search for reliable indicators of biological age, rather than chronological age, has been ongoing for over three decades, and until recently, largely without success. Advances in the fields of molecular biology have increased the variety of potential candidate biomarkers that may be considered as biological age predictors. In this review, we summarize current state-of-the-art…

1,283 citations Cite SaveGo to paper →

EBioMedicine template — frequently asked questions

How do I write a paper in the EBioMedicine format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the EBioMedicine template. When you export, DocuGuru compiles the paper into the official Elsevier format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does EBioMedicine use?
EBioMedicine uses Numbered (Elsevier) references, shown as numbered [1], [2] markers in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: [1] A. Smith, B. Jones, C. Lee, A representative article title, EBioMedicine 12 (2023) 45–58.
Do I need to know LaTeX to submit to EBioMedicine?
No. DocuGuru generates the elsarticle LaTeX class and compiles the PDF for you in the background, so you get a Elsevier-ready EBioMedicine document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the EBioMedicine template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the EBioMedicine format with correct headings, figures, tables, and numbered citations.
Who publishes EBioMedicine?
EBioMedicine is a multidisciplinary journal published by Elsevier. DocuGuru's EBioMedicine template matches Elsevier's official submission format.
Can I export a submission-ready EBioMedicine PDF?
Yes — DocuGuru produces a PDF built with the official EBioMedicine template (the elsarticle class) that is ready to submit to Elsevier, together with the matching LaTeX source files.
How much does the EBioMedicine template cost?
You can start writing in the EBioMedicine template for free. Exporting the final submission-ready EBioMedicine PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the EBioMedicine template